Author Archive for Successful IBO

4Life Research Donates $100,000 To Auburn University

 
 
Aburn University receives $100,000 gift from 4Life Research.  The Molecular and Applied Sciences Laboratory in the School of Kinesiology will use the $100,000 donation from 4Life Research to advance the science of 4Life products, study new ingredients, and conduct ongoing research in support of current and future products for distributors and customers alike.
4Life Chief Scientific Officer Chris Lockwood, PhD, CSCS: “As an industry leader, our investment in university research is an absolute necessity to 4Life’s corporate goals of innovation, substantiation, and education.”
“4Life works continually to establish product credibility through exploratory research.  Academic associations like this one with Auburn University are key to our strategic initiatives in the marketplace.” says 4Life President and CEO Steve Tew.
4Life’s donation to Auburn University will also fund the purchase of laboratory equipment, graduate student scholarships, and research-related faculty travel.
4Life Founder and Chairman of the Board David Lisonbee: “Research is in the name I used to launch the company. The science of transfer factor and supplementation is our foundation. We will continue to invest in the
ongoing work of our Health Sciences Advisory Board, patent acquisition,academic partnerships, and the leading technologies of our Research and Development team.”
About 4Life
4Life’s leading group of doctors, scientists, and researchers continue to

Read more...

Youngevity Reports Q2 Results Up 57% To $32.7 Million

 
 
Youngevity International, Inc., a global direct marketer of nutritional and lifestyle products and also a vertically-integrated producer of gourmet coffees for the commercial, retail and direct sales channels, today reported financial results for the second quarter of 2014.
2014 Second Quarter Highlights:

Net revenue increased 56.6% to $32.7 million compared to $20.9 million for the second quarter of 2013.
Gross profit increased 49.2% to $18.9 million compared to $12.7 million in the same period last year.
Operating Income was $1.2 million, an increase of 14.9% over the prior year period.
Adjusted EBITDA increased 17.5% to $2.0 million for the three months ended June 30, 2014 compared to $1.7 million in the same period for the prior year.

“Our quarterly results demonstrate the strength of our unique business model and we are very pleased to report record revenue,” stated Steve Wallach, Chairman and CEO of Youngevity International. “In the second quarter, we capitalized on strategic opportunities for our Company and we remain well positioned for long-term growth in the United States and globally.”
Dave Briskie, CFO of Youngevity International, said “We are very pleased to deliver record revenue and our eighth straight quarter of profitability. As in the first quarter, Q2 numbers carried a significant expense load related

Read more...

ForeverGreen Worldwide Announces Q2 2014 Results

 
 
ForeverGreen Worldwide Corporation, a leading provider of nutritional foods and other healthy products announced Q2 2014 earnings. The quarter ended June 30, 2014.
Recent Company Highlights:

New leaders, distributors and customers added at record pace each month during 2014
Company achieved fifth consecutive quarter of operating profitability and second consecutive quarter of growth in operating and net income
Sales increased each quarter for the last 5 quarters
Company actively shipped product in 174 countries, up from just 150 at end of 2013
Company added new product, SolarStrips, to product portfolio
Company expanded to new corporate headquarters in Pleasant Grove, UT
Company met or exceeded monthly targets necessary to remain on target for the increased company guidance of $41-50 million of revenue during 2014

Highlights for Q2 2014 included:

Sales increased to $14,127,840 from $4,007,611 for Q2 2013, a 253% increase
Gross profit rose to $11,233,332 compared to $2,852,371 during Q2 2013, a 294% increase
Gross profit margins increased to 79.5% versus 71.1% during the comparable quarter during 2013
Operating income was $412,360 compared to $92,653, a 345% increase
Net income totaled $454,856 or $0.02 EPS versus a net loss of $5,383
Operating expenses excluding sales and marketing declined as a percentage of revenue from 31.9% in 2013 to 24% in 2014
Interest expense decreased to $70,407

Read more...